Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Pfizer gets EU nod for Tagrisso rival Vizimpro

Pfizer gets EU nod for Tagrisso rival Vizimpro

Tarceva (erlotinib) and Boehringer Ingelheim’s second-generation Giotrif (afatinib) in the market.

Pfizer closes on EU approval of lung cancer drug Vizimpro

Pfizer closes on EU approval of lung cancer drug Vizimpro Vizimpro will now be able to compete directly with Iressa, Roche’s first-generation EGFR Tarceva (erlotinib) and newer drugs in the class such as Boehringer Ingelheim’s Giotrif (afatinib), although

FDA approval gained, Pfizer sets sights on first-line NSCLC market

FDA approval gained, Pfizer sets sights on first-line NSCLC market The second-generation EGFR tyrosine kinase inhibitor has been shown in trials to be more effective that first-generation drugs such as AstraZeneca’s Iressa (gefitinib) and Roche’s Tarceva (erlotinib) ... Approval now gained based on that data,

AZ’s soon-to-be lung cancer blockbuster Tagrisso approved in Japan

AZ’s soon-to-be lung cancer blockbuster Tagrisso approved in Japan The drug was also reviewed against other first-line EGFR tyrosine kinase inhibitors – Roche’s Tarceva and AZ’s and Teva’s Iressa – in previously untreated patients with locally-advanced or

Daiichi gets breakthrough status for pre-NDA leukaemia drug

Daiichi gets breakthrough status for pre-NDA leukaemia drug of HER3 inhibitor patritumab in combination with Roche’s EGFR drug Tarceva (erlotinib) in the same indication on disappointing efficacy data.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Empowering the MS patient through shared decision making
Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered...
What pharma marketers can learn from Disney
Why we need to continue to innovate, and surprise our audience...
Good data is nothing without advocacy
...

Infographics